Press/Media
-
Pharmacogenetics in the Toronto Star: "When the Cure is the Problem"
-
Six Questions Benefit Providers Should Ask Their PGx Partner
-
Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians
-
Inagene Diagnostics Inc. and Granville Biomedical Inc. team up to provide locally-produced pharmacogenetic testing kits to Canadians
-
Pharmacogenetic testing uses DNA to predict patients’ responses to medications
-
September's International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain…
-
Canada's surgery backlog could lead to wave of new chronic pain and opioid dependencies According to Inagene Diagnostics Inc., genetic testing can help mitigate the risk of chronic pain and reliance on medications
-
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing…
-
Inagene Pharmacogenetic Testing Featured on Global News
